Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation
- PMID: 11860427
- DOI: 10.1046/j.1524-4725.2002.00344.x
Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation
Abstract
Background: Polidocanol sclerotherapy is a well-established therapeutic modality for the treatment of venous malformations. Systemic complications are extremely rare.
Objective: To report a case of cardiac complication after polidocanol injection of peripheral venous malformation.
Methods: A case report and a review of the English language literature using a published MEDLINE search strategy.
Results: A patient undergoing polidocanol sclerotherapy for a symptomatic venous malformation of the right inferior limb developed cardiac arrest shortly after injection of the sclerosing agent which was promptly reversed.
Conclusion: Systemic complications following sclerotherapy may occur even when the sclerosant is injected in peripheral veins or venous malformations. Clinicians should be alerted to the possibility of uncommon but life-threatening adverse effects.
Similar articles
-
Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.J Clin Ultrasound. 2002 Sep;30(7):416-23. doi: 10.1002/jcu.10091. J Clin Ultrasound. 2002. PMID: 12210459
-
Color duplex-guided sclerotherapy for the treatment of venous malformations.Dermatol Surg. 2000 Apr;26(4):323-8. doi: 10.1046/j.1524-4725.2000.99248.x. Dermatol Surg. 2000. PMID: 10759818
-
Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol.Dermatol Surg. 2006 Nov;32(11):1410-3. doi: 10.1111/j.1524-4725.2006.32314.x. Dermatol Surg. 2006. PMID: 17083597 No abstract available.
-
Polidocanol for endovenous microfoam sclerosant therapy.Expert Opin Investig Drugs. 2009 Dec;18(12):1919-27. doi: 10.1517/13543780903376163. Expert Opin Investig Drugs. 2009. PMID: 19912070 Free PMC article. Review.
-
Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.Eur J Vasc Endovasc Surg. 2011 Mar;41(3):412-7. doi: 10.1016/j.ejvs.2010.10.009. Epub 2010 Dec 15. Eur J Vasc Endovasc Surg. 2011. PMID: 21111641 Review.
Cited by
-
Foam sclerotherapy for a symptomatic hepatic cyst: a preliminary report.Cardiovasc Intervent Radiol. 2014 Jun;37(3):800-4. doi: 10.1007/s00270-013-0761-5. Epub 2013 Oct 30. Cardiovasc Intervent Radiol. 2014. PMID: 24170168 Free PMC article.
-
Japanese clinical practice guidelines for vascular anomalies 2017.Pediatr Int. 2020 Mar;62(3):257-304. doi: 10.1111/ped.14077. Epub 2020 Mar 22. Pediatr Int. 2020. PMID: 32202048 Free PMC article.
-
Japanese clinical practice guidelines for vascular anomalies 2017.Jpn J Radiol. 2020 Apr;38(4):287-342. doi: 10.1007/s11604-019-00885-5. Jpn J Radiol. 2020. PMID: 32207066 Free PMC article.
-
Effects of blood flow control on clinical outcomes after ethanolamine oleate sclerotherapy for vascular malformations.Jpn J Radiol. 2009 Oct;27(8):297-302. doi: 10.1007/s11604-009-0341-4. Epub 2009 Oct 27. Jpn J Radiol. 2009. PMID: 19856224
-
Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches.Br J Radiol. 2014 Mar;87(1035):20130392. doi: 10.1259/bjr.20130392. Br J Radiol. 2014. PMID: 24588666 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical